Royalty Pharma Secures Drug Sales Royalties Through Pharmaceutical Funding
- 1Royalty Pharma provides funding to pharmaceutical and development companies in exchange for royalties on the sales of invested drugs.
- 2Royalty Pharma has a market capitalization of $28.44 billion and generates over $1 billion in sales from 16 blockbuster drugs.
- 3Royalty Pharma has increased its dividends every year since its listing in 2020.
So what's the key point?
Royalty Pharma lends money to pharmaceutical companies and receives a share of the profits when those drugs are sold. Because it has drugs generating over $1 billion in sales, it has increased its dividends every year.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.